These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

873 related articles for article (PubMed ID: 25174529)

  • 1. Assessment of the mode of action for hexavalent chromium-induced lung cancer following inhalation exposures.
    Proctor DM; Suh M; Campleman SL; Thompson CM
    Toxicology; 2014 Nov; 325():160-79. PubMed ID: 25174529
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhalation cancer risk assessment for environmental exposure to hexavalent chromium: Comparison of margin-of-exposure and linear extrapolation approaches.
    Proctor DM; Bhat V; Suh M; Reichert H; Jiang X; Thompson CM
    Regul Toxicol Pharmacol; 2021 Aug; 124():104969. PubMed ID: 34089813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human health risk and exposure assessment of chromium (VI) in tap water.
    Paustenbach DJ; Finley BL; Mowat FS; Kerger BD
    J Toxicol Environ Health A; 2003 Jul; 66(14):1295-339. PubMed ID: 12851114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An evaluation of the mode of action framework for mutagenic carcinogens case study II: chromium (VI).
    McCarroll N; Keshava N; Chen J; Akerman G; Kligerman A; Rinde E
    Environ Mol Mutagen; 2010 Mar; 51(2):89-111. PubMed ID: 19708067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Workplace airborne hexavalent chromium concentrations for the Painesville, Ohio, chromate production plant (1943-1971).
    Proctor DM; Panko JP; Liebig EW; Scott PK; Mundt KA; Buczynski MA; Barnhart RJ; Harris MA; Morgan RJ; Paustenbach DJ
    Appl Occup Environ Hyg; 2003 Jun; 18(6):430-49. PubMed ID: 12746066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chromium VI and stomach cancer: a meta-analysis of the current epidemiological evidence.
    Welling R; Beaumont JJ; Petersen SJ; Alexeeff GV; Steinmaus C
    Occup Environ Med; 2015 Feb; 72(2):151-9. PubMed ID: 25231674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hexavalent chromium exposures and exposure-control technologies in American enterprise: results of a NIOSH field research study.
    Blade LM; Yencken MS; Wallace ME; Catalano JD; Khan A; Topmiller JL; Shulman SA; Martinez A; Crouch KG; Bennett JS
    J Occup Environ Hyg; 2007 Aug; 4(8):596-618. PubMed ID: 17577750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hexavalent Chromium (Cr(VI)) Down-Regulates Acetylation of Histone H4 at Lysine 16 through Induction of Stressor Protein Nupr1.
    Chen D; Kluz T; Fang L; Zhang X; Sun H; Jin C; Costa M
    PLoS One; 2016; 11(6):e0157317. PubMed ID: 27285315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is hexavalent chromium carcinogenic via ingestion? A weight-of-evidence review.
    Proctor DM; Otani JM; Finley BL; Paustenbach DJ; Bland JA; Speizer N; Sargent EV
    J Toxicol Environ Health A; 2002 May; 65(10):701-46. PubMed ID: 12028825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The clastogenic effects of chronic exposure to particulate and soluble Cr(VI) in human lung cells.
    Holmes AL; Wise SS; Sandwick SJ; Wise JP
    Mutat Res; 2006 Nov; 610(1-2):8-13. PubMed ID: 16870495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of genotoxic potential of Cr(VI) in the mouse duodenum: an in silico comparison with mutagenic and nonmutagenic carcinogens across tissues.
    Thompson CM; Gregory Hixon J; Proctor DM; Haws LC; Suh M; Urban JD; Harris MA
    Regul Toxicol Pharmacol; 2012 Oct; 64(1):68-76. PubMed ID: 22705708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epithelial-mesenchymal transition during oncogenic transformation induced by hexavalent chromium involves reactive oxygen species-dependent mechanism in lung epithelial cells.
    Ding SZ; Yang YX; Li XL; Michelli-Rivera A; Han SY; Wang L; Pratheeshkumar P; Wang X; Lu J; Yin YQ; Budhraja A; Hitron AJ
    Toxicol Appl Pharmacol; 2013 May; 269(1):61-71. PubMed ID: 23518002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hexavalent chromium compounds in the workplace: assessing the extent and magnitude of occupational exposure in Italy.
    Scarselli A; Binazzi A; Marzio DD; Marinaccio A; Iavicoli S
    J Occup Environ Hyg; 2012; 9(6):398-407. PubMed ID: 22577838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chromium IV exposure, via Src/Ras signaling, promotes cell transformation.
    Ganapathy S; Li P; Lafontant J; Xiong R; Yu T; Zhang G; Chen C
    Mol Carcinog; 2017 Jul; 56(7):1808-1815. PubMed ID: 28218450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of hexavalent chromium on mammalian cell bioenergetics: phenotypic changes, molecular basis and potential relevance to chromate-induced lung cancer.
    Abreu PL; Ferreira LM; Alpoim MC; Urbano AM
    Biometals; 2014 Jun; 27(3):409-43. PubMed ID: 24664226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene 33/Mig6 inhibits hexavalent chromium-induced DNA damage and cell transformation in human lung epithelial cells.
    Park S; Li C; Zhao H; Darzynkiewicz Z; Xu D
    Oncotarget; 2016 Feb; 7(8):8916-30. PubMed ID: 26760771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estimating historical occupational exposure to airborne hexavalent chromium in a chromate production plant: 1940--1972.
    Proctor DM; Panko JP; Liebig EW; Paustenbach DJ
    J Occup Environ Hyg; 2004 Nov; 1(11):752-67. PubMed ID: 15673096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genotoxicity of 1,3-butadiene and its epoxy intermediates.
    Walker VE; Walker DM; Meng Q; McDonald JD; Scott BR; Seilkop SK; Claffey DJ; Upton PB; Powley MW; Swenberg JA; Henderson RF;
    Res Rep Health Eff Inst; 2009 Aug; (144):3-79. PubMed ID: 20017413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a cancer-based chronic inhalation reference value for hexavalent chromium based on a nonlinear-threshold carcinogenic assessment.
    Haney JT; Erraguntla N; Sielken RL; Valdez-Flores C
    Regul Toxicol Pharmacol; 2012 Dec; 64(3):466-80. PubMed ID: 23103602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of in vivo genotoxic and carcinogenic potency to augment mode of action analysis: Case study with hexavalent chromium.
    Thompson CM; Bichteler A; Rager JE; Suh M; Proctor DM; Haws LC; Harris MA
    Mutat Res Genet Toxicol Environ Mutagen; 2016 Apr; 800-801():28-34. PubMed ID: 27085472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 44.